rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1985-10-7
|
pubmed:abstractText |
C57BL mice are immunized by subcutaneous injection of the T2 syngeneic tumour (MCA fibrosarcoma), followed a week later by surgical removal of the tumour. Such mice can be made hyper-immune by challenging them with mitomycin C-treated T2 cells and they do not develop a tumour after a subsequent inoculum of live T2 cells. Lymph nodes near the site of tumour inoculation are removed after 2 weeks and histological studies show an increase in the number of macrophages and mast cells but not of Lyt-2+ lymphocytes.
|
pubmed:language |
fre
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0037-9026
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
179
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
122-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3161594-Animals,
pubmed-meshheading:3161594-Antigens, Neoplasm,
pubmed-meshheading:3161594-Fibrosarcoma,
pubmed-meshheading:3161594-Graft Rejection,
pubmed-meshheading:3161594-Immunization,
pubmed-meshheading:3161594-Lymph Nodes,
pubmed-meshheading:3161594-Macrophages,
pubmed-meshheading:3161594-Male,
pubmed-meshheading:3161594-Mast Cells,
pubmed-meshheading:3161594-Mice,
pubmed-meshheading:3161594-Mice, Inbred C57BL,
pubmed-meshheading:3161594-Neoplasm Transplantation,
pubmed-meshheading:3161594-T-Lymphocytes
|
pubmed:year |
1985
|
pubmed:articleTitle |
[Method of efficacious immunization against syngeneic murine sarcoma].
|
pubmed:publicationType |
Journal Article,
English Abstract
|